| ²é¿´: 1087 | »Ø¸´: 2 | |||
Ò©Éúľ³æ (ÕýʽдÊÖ)
|
[ÇóÖú]
¸Õ¸ÕÊÕµ½Éó¸åÒâ¼û£¬Çë³æÓѰïÎÒ¿´¿´ÕâÌõÉó¸åÒâ¼û¸ÃÈçºÎÀí½â£¬Ð»Ð»£¡×£¸÷λдºÓä¿ì£¡ ÒÑÓÐ2È˲ÎÓë
|
|
ËßÇóÈçÌâ¡£ ±³¾°£º 1¡¢ÎÒ×öµÄÊÇijҩÎï¶Ô¼¦ÂÑÇåµ°°×£¨OVA£©ËùÖÂÏø´Ð¡ÊóµÄ¸ÉÔ¤×÷Óã» 2¡¢Í¶µÄÔÓÖ¾ÊÇJournal of Ethnopharmacology¡£ÒÔÏÂΪÉó¸åÈËËùÌáÒâ¼û£¨*±íʾÎÒÓõÄÒ©Î£¬¿´Á˰ëÌìû¿´Ã÷°×ʲôÒâ˼£¬ÇëÈÈÐijæÓÑÌṩ°ïÖú¡£ It would be more useful if the statistical significance of the values listed for Tables 3 and 4, and the data presented in Figures 4,5, 6, 7, 8 and 9 are with reference to ovalbumin (OVA) sensitize group, since the efficacy of ***** and the control in an asthma model are being investigated. ×£´ó¼ÒдºÓä¿ì£¬ãؼһ¶ÀÖ£¡ ![]() ![]() |
» ²ÂÄãϲ»¶
²©Ê¿×Ô¼ö
ÒѾÓÐ3È˻ظ´
083200 ³õÊÔ305·Ö Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
292Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
22408 270·Ö
ÒѾÓÐ8È˻ظ´
Ò»Ö¾Ô¸2110£¬»¯Ñ§Ñ§Ë¶310·Ö£¬±¾¿ÆÖصãË«·ÇÇóµ÷¼Á
ÒѾÓÐ15È˻ظ´
070300»¯Ñ§Ñ§Ë¶311·ÖÇóµ÷¼Á
ÒѾÓÐ20È˻ظ´
085400 328·Ö Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
085801 ×Ü·Ö275 ±¾¿ÆÐÂÄÜÔ´ Çóµ÷¼Á
ÒѾÓÐ8È˻ظ´
0854µ÷¼Á
ÒѾÓÐ6È˻ظ´
280Çóµ÷¼Á
ÒѾÓÐ8È˻ظ´

irvine2015
ľ³æ (ÖøÃûдÊÖ)
- Ó¦Öú: 57 (³õÖÐÉú)
- ½ð±Ò: 5456
- ºì»¨: 7
- Ìû×Ó: 1933
- ÔÚÏß: 109.7Сʱ
- ³æºÅ: 3863593
- ×¢²á: 2015-05-11
- ÐÔ±ð: GG
- רҵ: ÖÊÆ×·ÖÎö
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
Ò©Éú: ½ð±Ò+10, ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸, ллÆÀÂÛ£¬ÎÒÔÚresultÀïÃæ±ê×¢³öÁ˸÷ÖÖPÖµ¡£ 2016-02-15 18:31:10
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
Ò©Éú: ½ð±Ò+10, ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸, ллÆÀÂÛ£¬ÎÒÔÚresultÀïÃæ±ê×¢³öÁ˸÷ÖÖPÖµ¡£ 2016-02-15 18:31:10
| ÓÉÓÚÄã×öµÄÒ©Îï¶Ô¼¦ÂÑÇåµ°°×£¨OVA£©ËùÖÂÏø´Ð¡ÊóµÄ¸ÉÔ¤×÷ÓÃÊÇÓÃÏø´Ä£Ð͵ĿØÖÆÑо¿¡£Éó¸åÒâ¼û½¨ÒéÄãÖØÐÂÃèÊö±í3ºÍ±í4ÖеÄÊý¾Ý£¬ÒÔ¼°Í¼4ÖÁ9µÄÊý¾Ý¶ÔÏò²ÎÕÕÂѰ׵°°×£¨OVA£©Ãô»¯»ùÍÅ¡£ |

2Â¥2016-02-11 01:10:24
jwr
ľ³æ (ÖøÃûдÊÖ)
- Ó¦Öú: 230 (´óѧÉú)
- ½ð±Ò: 4462.8
- ºì»¨: 16
- Ìû×Ó: 1336
- ÔÚÏß: 200.9Сʱ
- ³æºÅ: 483458
- ×¢²á: 2007-12-26
- ÐÔ±ð: GG
- רҵ: ÖÐÒ©ÖÊÁ¿ÆÀ¼Û
3Â¥2016-02-15 10:15:48














»Ø¸´´ËÂ¥